Home>>Signaling Pathways>> Metabolism>> Hydrolase>>ML-211

ML-211

Catalog No.GC12150

dual inhibitor of LYPLA1 and the related LYPLA2

Products are for research use only. Not for human use. We do not sell to patients.

ML-211 Chemical Structure

Cas No.: 2205032-89-7

Size Price Stock Qty
1mg
$52.00
In stock
5mg
$188.00
In stock
10mg
$323.00
In stock
25mg
$679.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description of ML-211

IC50: LYPLA1 (17 nM) and the related LYPLA2 (30 nM)

ML-211 is a dual inhibitor of LYPLA1 and the related LYPLA2.

Lysophospholipase 1 (LYPLA1), a protein palmitoyl thioesterase, is responsible for depalmitoylation of the oncogene HRas. Palmitoylation of such oncogenes is considered to be required for trafficking and malignant transformation, making LYPLA1 a promising target for downregulating oncogenic signaling.

In vitro: ML-211 was identified as a carbamate-based dual inhibitor of LYPLA1 and the related LYPLA2. ML-211 could inhibit the serine hydrolase ABHD11 with an IC50 value of 10 nM but was over 50-fold selective for LYPLA in a panel of 20 additional serine hydrolases. Given the high structural homology between LYPLA1 and LYPLA2, it was anticipated that ML211 modified LYPLA2 in an analogous manner. In additioin, out of more than 20 serine hydrolases (SHs), ML211 was observed to have one anti-target, alpha/beta hydrolase domain-containing protein 11 (ABHD11). ML211 and the anti-probe ML226 were evaluated for cell toxicity using both serum-free and serum-supplemented media, and the results showed that both compounds had a CC50 greater than 6 μM, which was 200-fold greater than the concentration necessary for complete inhibition of their respective target enzyme(s) [1].

In situ: It was found that both ML211 and ML226 were shown to be highly active in situ against their targets, completely inhibiting their target enzymes in serum-containing media after two hours at 30 nM concentration [1].

Clinical trial: So far, no clinical study has been conducted.

Reference:
[1] Adibekian, A. ,Martin, B.R.,Speers, A.E., et al. Optimization and characterization of a triazole urea dual inhibitor for lysophospholipase 1 (LYPLA1) and lysophospholipase 2 (LYPLA2). 1 R01 CA132630, 1-42 (2013).

Chemical Properties of ML-211

Cas No. 2205032-89-7 SDF
Chemical Name (4-(tert-butyl)piperidin-1-yl)(4-(hydroxydiphenylmethyl)-2H-1,2,3-triazol-2-yl)methanone
Canonical SMILES CC(C)(C)C1CCN(C(N2N=C(C(C3=CC=CC=C3)(O)C4=CC=CC=C4)C=N2)=O)CC1
Formula C25H30N4O2 M.Wt 418.5
Solubility ≤10mg/ml in ethanol;30mg/ml in DMSO;30mg/ml in dimethyl formamide Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of ML-211

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.3895 mL 11.9474 mL 23.8949 mL
5 mM 0.4779 mL 2.3895 mL 4.779 mL
10 mM 0.2389 mL 1.1947 mL 2.3895 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of ML-211

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Reviews

Review for ML-211

Average Rating: 5 ★★★★★ (Based on Reviews and 38 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ML-211

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.